title: Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa.
abstract: Salmonella spp. producing extended-spectrum beta-lactamases (ESBLs) have been reported in many countries, but there is no information on their prevalence in Africa. ESBL-producing Salmonella enterica serotype Isangi and S. enterica serotype Typhimurium strains have been noted in South Africa since 2001. A total of 160 consecutive isolates of Salmonella spp. were collected from 13 hospitals located in different cities in South Africa over a 5-month period from December 2002 to April 2003. All strains were screened for production of ESBLs by the double disk diffusion test and for AmpC production by assessing resistance to cefoxitin. bla(SHV), bla(TEM), bla(CTX-M), and bla(CMY-2) were sought from all ESBL-positive and cefoxitin-resistant isolates. A total of 15.6% (25 of 160) isolates produced SHV or TEM ESBLs, and 1.9% (3 of 160) produced CMY-2. Nine S. enterica serotype Typhimurium, eight S. enterica serotype Isangi, and three S. enterica serotype Muenchen strains produced either TEM-63 or a derivative of TEM-63 designated TEM-131. Both TEM-63 and TEM-131 have an isoelectric point of 5.6, and their sequences have the following amino acid substitutions compared to the TEM-1 sequence: Leu21Phe, Glu104Lys, Arg164Ser, and Met182Thr. Additionally, TEM-131 has an Ala237Thr substitution. ESBL-producing Salmonella spp. have become a significant public health problem in South Africa with particular implications for the treatment of serious nontyphoidal Salmonella infections in children, for whom extended-spectrum cephalosporins were the preferred treatment.
authors.affiliation: UPMC Division of Infectious Diseases, Suite 3A Falk Medical Building, 3601 5th Ave., Pittsburgh, PA 15213, USA. patersond@msx.dept-med.pitt.edu
authors.forename: Tersia
authors.initials: T
authors.lastname: Kruger
authors.forename: Dora
authors.initials: D
authors.lastname: Szabo
authors.forename: Karen H
authors.initials: KH
authors.lastname: Keddy
authors.forename: Kathleen
authors.initials: K
authors.lastname: Deeley
authors.forename: Jane W
authors.initials: JW
authors.lastname: Marsh
authors.forename: Andrea M
authors.initials: AM
authors.lastname: Hujer
authors.forename: Robert A
authors.initials: RA
authors.lastname: Bonomo
authors.forename: David L
authors.initials: DL
authors.lastname: Paterson
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004269:DNA, Bacterial / Q000235:genetics / Q000302:isolation & purification; D016521:Electrophoresis, Gel, Pulsed-Field; D004784:Environmental Monitoring; D062665:Epidemiological Monitoring; D007525:Isoelectric Focusing; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010641:Phenotype; D010957:Plasmids / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012475:Salmonella / Q000201:enzymology* / Q000235:genetics*; D012480:Salmonella Infections / Q000453:epidemiology / Q000382:microbiology*; D013019:South Africa / Q000453:epidemiology; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics*
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; C440929:beta-lactamase TEM-63; D001618:beta-Lactamases; C494142:beta-lactamase TEM-131, Salmonella